We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
SunCoke Energy
SXC
$797M
| $2.37M | 0.01% |
210,133
-131,581
| -39% | -$1.42M |
|
1327
Harmony Biosciences
HRMY
$2.24B
| $2.37M | 0.01% |
70,483
+60,479
| +605% | +$1.94M |
|
1328
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$364M
| $2.34M | 0.01% |
25,090
-61,600
| -71% | -$5.16M |
|
1329
Carriage Services
CSV
$569M
| $2.34M | 0.01% |
86,357
+8,791
| +11% | +$220K |
|
1330
V2X
VVX
$2.65B
| $2.33M | 0.01% |
49,964
+32,701
| +189% | +$1.34M |
|
1331
STAAR Surgical
STAA
$1.21B
| $2.33M | 0.01% |
+60,937
| New | +$1.98M |
|
1332
Jones Lang LaSalle
JLL
$16.7B
| $2.33M | 0.01% |
+11,921
| New | +$2.17M |
|
1333
Glaukos
GKOS
$10.6B
| $2.32M | 0.01% |
24,644
-54,857
| -69% | -$4.9M |
|
|
SLN
1334
Silence Therapeutics
SLN
$564M
| $2.32M | 0.01% |
+107,212
| New | +$2.33M |
|
1335
Immatics
IMTX
$1.32B
| $2.31M | 0.01% |
220,123
-113,893
| -34% | -$1.33M |
|
1336
Adecoagro
AGRO
$1.36B
| $2.31M | 0.01% |
209,716
-169,478
| -45% | -$1.74M |
|
1337
Sasol
SSL
$7.1B
| $2.31M | 0.01% |
295,853
+42,322
| +17% | +$348K |
|
|
IAS
1338
DELISTED
Integral Ad Science
IAS
| $2.31M | 0.01% |
231,734
-540,231
| -70% | -$7.21M |
|
|
LBPH
1339
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $2.31M | 0.01% |
+106,885
| New | +$2.33M |
|
1340
Ranpak Holdings
PACK
$473M
| $2.31M | 0.01% |
293,352
+250,851
| +590% | +$1.32M |
|
|
PRO
1341
DELISTED
PROS Holdings
PRO
| $2.31M | 0.01% |
63,544
-11,787
| -16% | -$417K |
|
1342
iRhythm Holdings
IRTC
$4.2B
| $2.31M | 0.01% |
+19,900
| New | +$2.24M |
|
1343
Green Plains
GPRE
$1.03B
| $2.31M | 0.01% |
99,774
-93,915
| -48% | -$2.06M |
|
1344
Build-A-Bear
BBW
$462M
| $2.3M | 0.01% |
77,100
-49,505
| -39% | -$1.19M |
|
1345
Walt Disney
DIS
$181B
| $2.3M | 0.01% |
18,800
-895,976
| -98% | -$93.6M |
|
1346
ArcBest
ARCB
$3.08B
| $2.3M | 0.01% |
16,113
-787
| -5% | -$103K |
|
1347
Companhia Siderúrgica Nacional
SID
$1.23B
| $2.3M | 0.01% |
733,419
+473,219
| +182% | +$1.64M |
|
|
EGLE
1348
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $2.29M | 0.01% |
36,722
+22,916
| +166% | +$1.34M |
|
1349
TriNet
TNET
$3.14B
| $2.29M | 0.01% |
17,256
+1,856
| +12% | +$225K |
|
1350
RPC Inc
RES
$1.3B
| $2.28M | 0.01% |
295,218
-389,709
| -57% | -$2.81M |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.